Conference Agenda

Programme for the Anglonordic Biotech Conference VII, 2010

April 14	The conference starts with a drink reception at the Spanish Ambassador’s Residence in London the evening before the event. Spain is the Guest Country 2010 and the drink reception starts at 18.00. (Please note that there is a separate registration for the drink reception)

April 15
09.00 – 09.40	Registration at 1VS Westminister Conference Centre, 1 Victoria Street, London, SW1
09.40 – 10.00	Welcome on behalf of Chairman – Hans Boström, Director, Scientific Liaison Licensing and External Research, Europe, Merck Sharp & Dome
10.00 – 10.45	Partnering pitches - Creative Antibiotics - www.creativeantibiotics.com - Heptares Therapeutices - www.heptares.com
10.45 – 11.15	The new Merck- Expanded areas for external partnerships, Margaret Beer, Senior Director and Head Licensing and External Research Europe, Merck Sharp & Dome
11.15 – 11.25	Q&A with Merck
11.25 – 11.45	Regulatory challenges in global development - How to fulfill EU and US regulatory requirements, Dr Ulrich Granzer, CEO, Granzer Regulatory Consulting & Services
11.45 – 11.55	The Conference Guest Country Spain introduces – Spain and biotech: a surprising and sucessful combination
11.55 – 13.00	LUNCH
13.00 – 14.00	If I knew then what I Know Today (Panel discussion) Moderator: Mike Ward, Senior Editor, Biocentury Panel: - Keith McCullagh, Chairman of Clavis Pharma ASA and Affitech AS - Claus Møller, CEO, IPC International A/S - Jeremy Curnock Cook, Chairman, International Bioscience Managers Ltd
14.00 – 14.15	Turbocharging biotech in Oslo – Oslo Cancer Cluster Innovation Park, Bjarte Reve, CEO, Oslo Cancer Cluster
14.15 – 15.00	Partnering pitches - Lytix Biopharma - www.lytixbiopharma.com - Tbc
15.00 – 15.30	Tbc
15.30 – 16.00	Latest News on European Funding - Regina Hodits, Partner, Atlas Venture
16.00 – 16.15	Conclusions and Q&A
16.15 – 18.30	Afternoon Buffet and Drinks